PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 167 filers reported holding PRECIGEN INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,871 | +9.7% | 1,317,290 | -11.2% | 0.00% | +50.0% |
| Q2 2023 | $1,706 | -26.5% | 1,483,590 | -32.3% | 0.00% | -33.3% |
| Q1 2023 | $2,322 | +108.4% | 2,190,790 | +198.8% | 0.00% | +50.0% |
| Q4 2022 | $1,114 | -99.9% | 733,203 | -12.2% | 0.00% | -33.3% |
| Q3 2022 | $1,771,000 | -11.4% | 835,499 | -44.0% | 0.00% | +50.0% |
| Q2 2022 | $2,000,000 | -20.2% | 1,492,690 | +25.7% | 0.00% | -33.3% |
| Q1 2022 | $2,506,000 | +828.1% | 1,187,590 | +1530.2% | 0.00% | – |
| Q4 2021 | $270,000 | -87.7% | 72,851 | -83.4% | 0.00% | -100.0% |
| Q3 2021 | $2,187,000 | +512.6% | 438,187 | +746.1% | 0.00% | – |
| Q1 2021 | $357,000 | -81.2% | 51,787 | -72.2% | 0.00% | -100.0% |
| Q4 2020 | $1,900,000 | – | 186,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |